Involvement of Hypoxia-Inducible Transcription Factors in Polycystic Kidney Disease
- 31 March 2007
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 170 (3), 830-842
- https://doi.org/10.2353/ajpath.2007.060455
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- The VHL/HIF oxygen-sensing pathway and its relevance to kidney diseaseKidney International, 2006
- Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancerNature Medicine, 2005
- The insulin-PI3K/TOR pathway induces a HIF-dependent transcriptional response in Drosophila by promoting nuclear localization of HIF-α/SimaJournal of Cell Science, 2005
- Differentiating the functional role of hypoxia‐inducible factor (HIF)‐1α and HIF‐2α (EPAS‐1) by the use of RNA interference: erythropoietin is a HIF‐2α target gene in Hep3B and Kelly cellsThe FASEB Journal, 2004
- Small Molecule-Mediated Anti-Cancer Therapy via Hypoxia Inducible Factor-1 BlockadeCancer Biology & Therapy, 2004
- Recent Advances in Understanding the Pathogenesis of Polycystic Kidney DiseaseDrugs, 2004
- Widespread, hypoxia‐inducible expression of HIF‐2α in distinct cell populations of different organsThe FASEB Journal, 2002
- Anemia and End‐Stage Renal Disease in the Developing WorldArtificial Organs, 2002
- Characterization of the Han:SPRD rat model for hereditary polycystic kidney diseaseKidney International, 1994
- Serum Immunoreactive Erythropoietin Levels in Patients with Polycystic Kidney Disease as Compared with Other Hemodialysis PatientsNephron, 1985